Abiopharma

Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA® (ustékinumab), un biosimilaire de référence à STELARA® (ustékinumab) au Canada

Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress

Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada

Citi and CREATE-Research Report: Innovation in Asset Management Pivots to ‘Operational Alpha’

Global Net Lease, Inc. Announces Preferred Stock Dividends

Premier Graphene Inc. (OTC: BIEI) Currently Anticipates Reporting First Profitable Quarter in Company History

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

Forrester abre el plazo de presentación de candidaturas para sus 2026 B2B Awards en EMEA

Opening of Trading on June 19 2026-FATTAL HOLD B6